ACS Sensors,
Journal Year:
2024,
Volume and Issue:
9(9), P. 4469 - 4494
Published: Sept. 9, 2024
Lung
cancer
remains
a
global
health
concern,
demanding
the
development
of
noninvasive,
prompt,
selective,
and
point-of-care
diagnostic
tools.
Correspondingly,
breath
analysis
using
nanobiosensors
has
emerged
as
promising
noninvasive
nose-on-chip
technique
for
early
detection
lung
through
monitoring
diversified
biomarkers
such
volatile
organic
compounds/gases
in
exhaled
breath.
This
comprehensive
review
summarizes
state-of-the-art
breath-based
diagnosis
employing
chemiresistive-module
supported
by
theoretical
findings.
It
unveils
fundamental
mechanisms
biological
basis
biomarker
generation
associated
with
cancer,
technological
advancements,
clinical
implementation
nanobiosensor-based
analysis.
explores
merits,
challenges,
potential
alternate
solutions
implementing
these
settings,
including
standardization,
biocompatibility/toxicity
analysis,
green
sustainable
technologies,
life-cycle
assessment,
scheming
regulatory
modalities.
highlights
nanobiosensors'
role
facilitating
precise,
real-time,
on-site
leading
to
improved
patient
outcomes,
enhanced
management,
remote
personalized
monitoring.
Additionally,
integrating
biosensors
artificial
intelligence,
machine
learning,
Internet-of-things,
bioinformatics,
omics
technologies
is
discussed,
providing
insights
into
prospects
intelligent
sniffing
nanobiosensors.
Overall,
this
consolidates
knowledge
on
breathomic
biosensor-based
screening,
shedding
light
its
significance
applications
advancing
medical
diagnostics
reduce
burden
hospitals
save
human
lives.
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
34(16)
Published: Dec. 12, 2021
Abstract
Medical
robots
are
invaluable
players
in
non‐pharmaceutical
treatment
of
disabilities.
Particularly,
using
prosthetic
and
rehabilitation
devices
with
human–machine
interfaces
can
greatly
improve
the
quality
life
for
impaired
patients.
In
recent
years,
flexible
electronic
soft
robotics
have
attracted
tremendous
attention
this
field
due
to
their
high
biocompatibility,
functionality,
conformability,
low‐cost.
Flexible
on
will
make
a
promising
alternative
conventional
rigid
devices,
which
potentially
revolutionize
paradigm
future
direction
medical
terms
feedback
user
experience.
review,
fundamental
components
materials,
structures,
mechanisms
human‐machine
summarized
by
renowned
applications
five
primary
areas:
physical
chemical
sensing,
physiological
recording,
information
processing
communication,
robotic
actuation,
stimulation.
This
review
further
concludes
discussing
outlook
current
challenges
these
technologies
as
interface
robotics.
ACS Nano,
Journal Year:
2022,
Volume and Issue:
16(5), P. 7080 - 7115
Published: May 5, 2022
This
paper
provides
an
overview
of
recent
developments
in
the
field
volatile
organic
compound
(VOC)
sensors,
which
are
finding
uses
healthcare,
safety,
environmental
monitoring,
food
and
agriculture,
oil
industry,
other
fields.
It
starts
by
briefly
explaining
basics
VOC
sensing
reviewing
currently
available
quickly
progressing
approaches.
then
discusses
main
trends
materials'
design
with
special
attention
to
nanostructuring
nanohybridization.
Emerging
materials
strategies
highlighted
their
involvement
different
types
technologies
is
discussed,
including
optical,
electrical,
gravimetric
sensors.
The
review
also
detailed
discussions
about
limitations
offers
potential
solutions.
status
suggestions
promising
directions
for
future
development
summarized.
ACS Nano,
Journal Year:
2020,
Volume and Issue:
14(12), P. 16180 - 16193
Published: Dec. 14, 2020
The
management
of
the
COVID-19
pandemic
has
relied
on
cautious
contact
tracing,
quarantine,
and
sterilization
protocols
while
we
await
a
vaccine
to
be
made
widely
available.
Telemedicine
or
mobile
health
(mHealth)
is
well-positioned
during
this
time
reduce
potential
disease
spread
prevent
overloading
healthcare
system
through
at-home
screening,
diagnosis,
monitoring.
With
rise
mass-fabricated
electronics
for
wearable
portable
sensors,
emerging
telemedicine
tools
have
been
developed
address
shortcomings
in
diagnostics,
monitoring,
management.
In
Perspective,
summarize
current
implementations
mHealth
sensors
COVID-19,
highlight
recent
technological
advances,
provide
an
overview
how
these
may
utilized
better
control
pandemic.
Analytical Chemistry,
Journal Year:
2021,
Volume and Issue:
93(24), P. 8585 - 8594
Published: June 3, 2021
The
global
pandemic
caused
by
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
virus
has
revealed
urgent
need
for
accurate,
rapid,
and
affordable
diagnostic
tests
epidemic
understanding
management
monitoring
population
worldwide.
Though
current
methods
including
real-time
polymerase
chain
reaction
(RT-PCR)
provide
sensitive
detection
of
SARS-CoV-2,
they
require
relatively
long
processing
time,
equipped
laboratory
facilities,
highly
skilled
personnel.
Laser-scribed
graphene
(LSG)-based
biosensing
platforms
have
gained
enormous
attention
as
miniaturized
electrochemical
systems,
holding
an
potential
point-of-care
(POC)
tools.
We
describe
here
a
LSG-based
sensing
scheme
disease
2019
(COVID-19)
diagnosis
combined
with
three-dimensional
(3D)
gold
nanostructures.
This
electrode
was
modified
SARS-CoV-2
spike
protein
antibody
following
proper
surface
modifications
proved
X-ray
photoelectron
spectroscopy
(XPS)
scanning
electron
microscopy
(SEM)
characterizations
well
techniques.
system
integrated
into
handheld
POC
operated
using
custom
smartphone
application,
providing
user-friendly
platform
due
to
its
ease
operation,
accessibility,
systematic
data
management.
analytical
features
immunoassay
were
evaluated
standard
solution
S-protein
in
range
5.0-500
ng/mL
limit
2.9
ng/mL.
A
clinical
study
carried
out
on
23
patient
blood
serum
samples
successful
COVID-19
diagnosis,
compared
commercial
RT-PCR,
test,
enzyme-linked
immunosorbent
assay
(ELISA)
IgG
IgA
test
results.
Our
provides
faster
results
tools
offers
promising
alternative
next-generation
applications.
ACS Nano,
Journal Year:
2021,
Volume and Issue:
15(3), P. 3557 - 3567
Published: Feb. 23, 2021
Due
to
the
limited
ability
of
conventional
methods
and
perspective
human
diagnostics,
patients
are
often
diagnosed
incorrectly
or
at
a
late
stage
as
their
disease
condition
progresses.
They
may
then
undergo
unnecessary
treatments
due
inaccurate
diagnoses.
In
this
Perspective,
we
offer
brief
overview
on
integration
nanotechnology-based
medical
sensors
artificial
intelligence
(AI)
for
advanced
clinical
decision
support
systems
help
decision-makers
healthcare
improve
how
they
approach
information,
insights,
surrounding
contexts,
well
promote
uptake
personalized
medicine
an
individualized
basis.
Relying
these
milestones,
wearable
sensing
devices
could
enable
interactive
evolving
decisions
that
be
used
evidence-based
analysis
recommendations
monitoring
progress
treatment.
We
present
discuss
ongoing
challenges
future
opportunities
associated
with
AI-enabled
in
decisions.
Analytical and Bioanalytical Chemistry,
Journal Year:
2020,
Volume and Issue:
413(1), P. 49 - 71
Published: Oct. 18, 2020
The
unprecedented
global
pandemic
known
as
SARS-CoV-2
has
exercised
to
its
limits
nearly
all
aspects
of
modern
viral
diagnostics.
In
doing
so,
it
illuminated
both
the
advantages
and
limitations
current
technologies.
Tremendous
effort
been
put
forth
expand
our
capacity
diagnose
this
deadly
virus.
work,
we
key
observations
in
functionality
methods
for
diagnostic
testing.
These
include
nucleic
acid
amplification-,
CRISPR-,
sequencing-,
antigen-,
antibody-based
detection
methods.
Additionally,
analysis
equally
critical
COVID-19
diagnostics,
including
sample
collection
preparation,
testing
models,
commercial
response.
We
emphasize
integrated
nature
assays,
wherein
issues
preparation
could
impact
overall
performance
a
clinical
setting.
Frontiers in Medicine,
Journal Year:
2021,
Volume and Issue:
8
Published: May 7, 2021
Diagnostic
testing
plays
a
critical
role
in
addressing
the
coronavirus
disease
2019
(COVID-19)
pandemic,
caused
by
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2).
Rapid
and
accurate
diagnostic
tests
are
imperative
for
identifying
managing
infected
individuals,
contact
tracing,
epidemiologic
characterization,
public
health
decision
making.
Laboratory
may
be
performed
based
on
symptomatic
presentation
or
screening
of
asymptomatic
people.
Confirmation
SARS-CoV-2
infection
is
typically
nucleic
acid
amplification
(NAAT),
which
requires
specialized
equipment
training
particularly
challenging
resource-limited
settings.
NAAT
give
false-negative
results
due
to
timing
sample
collection
relative
infection,
improper
sampling
respiratory
specimens,
inadequate
preservation
samples,
technical
limitations;
false-positives
occur
errors,
contamination
during
manual
real-time
polymerase
chain
reaction
(RT-PCR)
process.
Thus,
clinical
presentation,
history
contemporary
phyloepidemiology
must
considered
when
interpreting
results.
Several
sample-to-answer
platforms,
including
high-throughput
systems
Point
Care
(PoC)
assays,
have
been
developed
increase
capacity
decrease
errors.
Alternatives
RT-PCR
assay,
such
as
other
RNA
detection
methods
antigen
appropriate
certain
situations,
While
sequencing
important
monitor
on-going
evolution
genome,
antibody
assays
useful
purposes.
The
ever-expanding
assortment
tests,
with
varying
utility,
performance
requirements,
limitations,
merits
comparative
evaluation.
We
herein
provide
comprehensive
review
currently
available
COVID-19
diagnostics,
exploring
their
pros
cons
well
indications.
Strategies
further
optimize
safety,
speed,
ease
without
compromising
accuracy
suggested.
Access
scalable
tools
continued
technologic
advances,
machine
learning
smartphone
integration,
will
facilitate
control
current
pandemic
preparedness
next
one.